$2.85
-0.09-3.06%
At close: -
$2.79
-0.06-2.08%
After Hours: 4:52 PM EDT
Comments
Loading...
InMed Pharmaceuticals Stock Price, Quotes and Forecasts
INMNASDAQ
InMed Pharmaceuticals (INM) Forecast
NewsEarningsInMed Pharmaceuticals (INM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
InMed Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:INM | Benzinga
Explore InMed Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy InMed Pharmaceuticals (INM) stock?
You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.
Who are InMed Pharmaceuticals (INM) competitors?
There are no as such competitors for InMed Pharmaceuticals.
What is the forecast, or price target, for InMed Pharmaceuticals (INM) stock?
There is no analysis for InMed Pharmaceuticals to provide a consensus price target.
What is the current price for InMed Pharmaceuticals (INM)?
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $2.7906 last updated March 3, 2025 at 4:52 PM EST.
Does InMed Pharmaceuticals (INM) pay a dividend?
There are no upcoming dividends for InMed Pharmaceuticals.
When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?
InMed Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, May 13, 2025.
Is InMed Pharmaceuticals (INM) going to split?
There is no upcoming split for InMed Pharmaceuticals.
What sector and industry does InMed Pharmaceuticals (INM) operate in?
InMed Pharmaceuticals is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.